| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-902-60 | 62135-902 | HUMAN PRESCRIPTION DRUG | Rivastigmine Tartrate | Rivastigmine Tartrate | CAPSULE | ORAL | 20230104 | N/A | ANDA | ANDA207797 | Chartwell RX, LLC | RIVASTIGMINE TARTRATE | 4.5 mg/1 | 60 CAPSULE in 1 BOTTLE (62135-902-60) |
| 62135-903-60 | 62135-903 | HUMAN PRESCRIPTION DRUG | Rivastigmine Tartrate | Rivastigmine Tartrate | CAPSULE | ORAL | 20230104 | N/A | ANDA | ANDA207797 | Chartwell RX, LLC | RIVASTIGMINE TARTRATE | 6 mg/1 | 60 CAPSULE in 1 BOTTLE (62135-903-60) |
| 62135-901-60 | 62135-901 | HUMAN PRESCRIPTION DRUG | Rivastigmine Tartrate | Rivastigmine Tartrate | CAPSULE | ORAL | 20230104 | N/A | ANDA | ANDA207797 | Chartwell RX, LLC | RIVASTIGMINE TARTRATE | 3 mg/1 | 60 CAPSULE in 1 BOTTLE (62135-901-60) |
| 62135-900-60 | 62135-900 | HUMAN PRESCRIPTION DRUG | Rivastigmine Tartrate | Rivastigmine Tartrate | CAPSULE | ORAL | 20230104 | N/A | ANDA | ANDA207797 | Chartwell RX, LLC | RIVASTIGMINE TARTRATE | 1.5 mg/1 | 60 CAPSULE in 1 BOTTLE (62135-900-60) |